Jan 11, 2016: Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21)

by / Thursday, 22 October 2015 / Published in funding opportunities

The purpose of this Funding Opportunity Announcement (FOA) is to support hypothesis-generating research on innate and adaptive immune responses induced by mycobacterial infection, Bacillus Calmette-Guérin vaccine (BCG), or otherMycobacterium tuberculosis (Mtb) vaccinations.  Studies that include evaluation of immune responses by anatomical location in HIV-infected or uninfected individuals are of particular interest.  A secondary objective of this FOA is development of new assays and technologies enabling comparison of mycobacterial-specific mucosal and systemic immunological pathways in HIV-infected or uninfected individuals that can be used to monitor immune responses in preclinical studies and vaccine trials to advance Mtb vaccine development.

Application deadline: January 11, 2016

For more information and application instructions, please visit: 

TOP UA-36873340-1